Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SARAH R DANIELS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1861652711
CMS profile
129719
Location
AUSTIN, TX

General Payments · PY2018–2024

$1,555.12

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$667.51

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $667.51 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $254.92 14
Abbott Laboratories $170.16 11
Novo Nordisk AS $119.27 6
PFIZER INC. $46.05 2
Lilly USA, LLC $38.58 2
Alvogen Inc $22.36 1
ABBVIE INC. $16.17 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $126.97 8
PY2019 $78.19 5
PY2020 $49.54 3
PY2022 $97.06 5
PY2023 $535.85 30
PY2024 $667.51 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $2.11 01/17/2024 Food and Beverage Undisputed 01/23/2026 1125309652 CMS
Abbott Laboratories $18.68 02/06/2024 Food and Beverage Undisputed 01/23/2026 1125309654 CMS
Abbott Laboratories $27.66 03/20/2024 Food and Beverage Undisputed 01/23/2026 1125309656 CMS
Abbott Laboratories $7.27 04/12/2024 Food and Beverage Undisputed 01/23/2026 1125309658 CMS
Abbott Laboratories $6.09 04/12/2024 Food and Beverage Undisputed 01/23/2026 1125309660 CMS
Abbott Laboratories $31.81 04/30/2024 Food and Beverage Undisputed 01/23/2026 1125309662 CMS
Abbott Laboratories $7.65 06/20/2024 Food and Beverage Undisputed 01/23/2026 1125309664 CMS
Abbott Laboratories $6.56 07/08/2024 Food and Beverage Undisputed 01/23/2026 1125309666 CMS
Abbott Laboratories $29.97 08/05/2024 Food and Beverage Undisputed 01/23/2026 1125309672 CMS
Abbott Laboratories $6.01 08/28/2024 Food and Beverage Undisputed 01/23/2026 1125309668 CMS
Abbott Laboratories $26.35 10/14/2024 Food and Beverage Undisputed 01/23/2026 1125309670 CMS
ABBVIE INC. $16.17 02/19/2024 Food and Beverage Undisputed 01/23/2026 1103599552 CMS
Alvogen Inc $22.36 03/06/2024 Food and Beverage Undisputed 01/23/2026 1137624028 CMS
GlaxoSmithKline, LLC. $12.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 1116460687 CMS
GlaxoSmithKline, LLC. $18.25 02/07/2024 Food and Beverage Undisputed 01/23/2026 1116565684 CMS
GlaxoSmithKline, LLC. $18.05 02/21/2024 Food and Beverage Undisputed 01/23/2026 1116649117 CMS
GlaxoSmithKline, LLC. $18.40 03/06/2024 Food and Beverage Undisputed 01/23/2026 1116569615 CMS
GlaxoSmithKline, LLC. $16.64 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116552271 CMS
GlaxoSmithKline, LLC. $0.17 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116693975 CMS
GlaxoSmithKline, LLC. $24.42 06/17/2024 Food and Beverage Undisputed 01/23/2026 1116265402 CMS
GlaxoSmithKline, LLC. $20.26 06/25/2024 Food and Beverage Undisputed 01/23/2026 1115825563 CMS
GlaxoSmithKline, LLC. $20.06 07/24/2024 Food and Beverage Undisputed 01/23/2026 1115878438 CMS
GlaxoSmithKline, LLC. $19.88 08/26/2024 Food and Beverage Undisputed 01/23/2026 1116378130 CMS
GlaxoSmithKline, LLC. $26.16 10/07/2024 Food and Beverage Undisputed 01/23/2026 1116572187 CMS
GlaxoSmithKline, LLC. $18.33 11/04/2024 Food and Beverage Undisputed 01/23/2026 1115945424 CMS
GlaxoSmithKline, LLC. $22.86 11/22/2024 Food and Beverage Undisputed 01/23/2026 1116235985 CMS
GlaxoSmithKline, LLC. $18.88 12/02/2024 Food and Beverage Undisputed 01/23/2026 1116292781 CMS
Lilly USA, LLC $22.52 01/22/2024 Food and Beverage Undisputed 01/23/2026 1135376394 CMS
Lilly USA, LLC $16.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 1135376396 CMS
Novo Nordisk Inc $18.64 02/27/2024 Food and Beverage Undisputed 01/23/2026 1097204320 CMS
Novo Nordisk Inc $14.82 04/30/2024 Food and Beverage Undisputed 01/23/2026 1097097548 CMS
Novo Nordisk Inc $17.92 05/20/2024 Food and Beverage Undisputed 01/23/2026 1097306158 CMS
Novo Nordisk Inc $26.88 09/03/2024 Food and Beverage Undisputed 01/23/2026 1097403141 CMS
Novo Nordisk Inc $14.36 09/26/2024 Food and Beverage Undisputed 01/23/2026 1096913784 CMS
Novo Nordisk Inc $26.65 12/18/2024 Food and Beverage Undisputed 01/23/2026 1096655822 CMS
PFIZER INC. $29.30 07/17/2024 Food and Beverage Undisputed 01/23/2026 1131792083 CMS
PFIZER INC. $16.75 12/03/2024 Food and Beverage Undisputed 01/23/2026 1131260275 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.